DK3085381T3 - Orodispersibel desmopressin til forøgelse den initielle periode af søvn uforstyret af nyturi - Google Patents
Orodispersibel desmopressin til forøgelse den initielle periode af søvn uforstyret af nyturi Download PDFInfo
- Publication number
- DK3085381T3 DK3085381T3 DK16165875.2T DK16165875T DK3085381T3 DK 3085381 T3 DK3085381 T3 DK 3085381T3 DK 16165875 T DK16165875 T DK 16165875T DK 3085381 T3 DK3085381 T3 DK 3085381T3
- Authority
- DK
- Denmark
- Prior art keywords
- desmopressin
- composition
- nocturnal
- dose
- use according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Claims (18)
1. Sammensætning omfattende desmopressin til anvendelse til behandling af en mandlig patient, der har nyturi eller natlig polyuri, ved at reducere antallet af natlige blæretømninger fra den mandlige patient, der har behov derfor, hvor sammensætningen omfatter en orodispersibel dosis desmopressin på 25 pg til indgivelse før sengetid, hvor dosen er målt som den frie base af desmopressin.
2. Sammensætning omfattende desmopressin til anvendelse ved behandling af en mandlig patient, der har nyturi eller nattlig polyuri, ved at reducere natligt urinvolumen hos den mandlige patient, der har behov derfor, hvor sammensætningen omfatter en orodispersibel dosis desmopressin på 25 pg til indgivelse før sengetid, hvor dosen måles som den frie base af desmo-pressin.
3. Sammensætning til anvendelse ifølge krav 1 eller 2, hvor dosis er taget fra 0,8 til 3 timer før patientens sengetid; og/eller hvor dosen tages én gang dagligt.
4. Sammensætning til anvendelse ifølge krav 1-3, hvor dosen af desmopressinfri base tilføres i form af acetatsaltet af desmopressin.
5. Sammensætning til anvendelse ifølge krav 1-3, hvor den orodispersible dosis desmopressin er en doseringsform omfattende desmopressinacetat, gelatine, mannitol og citronsyre.
6. Sammensætning til anvendelse ifølge krav 1-5, hvor behandlingen gives over en behandlingsperiode.
7. Sammensætning til anvendelse ifølge krav 1-5, hvor behandlingsperioden er mindst 28 dage.
8. Sammensætning til anvendelse ifølge krav 1-7, hvor patienten har en urinproduktionshastighed under søvn, der er større end patientens samlede gennemsnitlige daglige urinproduktionshastighed.
9. Sammensætning til anvendelse ifølge krav 1-8, hvor patienten er over 65 år.
10. Sammensætning til anvendelse ifølge krav 9, hvor patienten har en serumkoncentration af natrium på mindst 135 mmol/l efter indgivelse.
11. Sammensætning omfattende desmopressin til anvendelse til behandling af en kvindelig patient, der har nyturi eller nattlig polyuri, ved at reducere antallet af natlige blæretømninger hos den kvindelige patient, der har behov derfor, hvor sammensætningen omfatter en orodispersibel dosis desmopressin på 10 pg til indgivelse før sengetid, hvor dosen måles som den frie base af desmopressin.
12. Sammensætning til anvendelse ifølge krav 11 til behandling afen kvindelig patient på over 50 år.
13. Sammensætning til anvendelse ifølge krav 11 til behandling af en kvindelig patient på over 65 år.
14. Sammensætning til anvendelse ifølge krav 11-13, hvor dosen af desmopressinfri base tilføres i form af acetatsaltet af desmopressin.
15. Sammensætning til anvendelse ifølge krav 11-13, hvor den orodispersible des-mopressindosis er en doseringsform omfattende desmopressinacetat, gelatine, mannitol og citronsyre.
16. Sammensætning til anvendelse ifølge krav 11-15, hvor behandlingen gives over en behandlingsperiode.
17. Sammensætning til anvendelse ifølge krav 11-15, hvor behandlingsperioden er mindst 28 dage.
18. Sammensætning til anvendelse ifølge krav 11, hvor patienten har en urinproduktionshastighed under søvn, der er større end patientens samlede gennemsnitlige daglige urinproduktionshastighed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5512008P | 2008-05-21 | 2008-05-21 | |
EP13181216.6A EP2712622B1 (en) | 2008-05-21 | 2009-05-21 | Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3085381T3 true DK3085381T3 (da) | 2018-05-28 |
Family
ID=41100519
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13181216.6T DK2712622T3 (da) | 2008-05-21 | 2009-05-21 | Orodispergibel desmopressin til forlængelse af indledende søvnperiode, uforstyrret af nykturi. |
DK17171155T DK3225250T3 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi |
DK09751584.5T DK2296686T4 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forlængelse af indledende søvnfase uforstyrret af nykturi |
DK17171152.6T DK3225249T3 (da) | 2008-05-21 | 2009-05-21 | Orodispergerbar desmopressin til at øge indledende periode med søvn uforstyrret af nykturi |
DK16165875.2T DK3085381T3 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forøgelse den initielle periode af søvn uforstyret af nyturi |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13181216.6T DK2712622T3 (da) | 2008-05-21 | 2009-05-21 | Orodispergibel desmopressin til forlængelse af indledende søvnperiode, uforstyrret af nykturi. |
DK17171155T DK3225250T3 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi |
DK09751584.5T DK2296686T4 (da) | 2008-05-21 | 2009-05-21 | Orodispersibel desmopressin til forlængelse af indledende søvnfase uforstyrret af nykturi |
DK17171152.6T DK3225249T3 (da) | 2008-05-21 | 2009-05-21 | Orodispergerbar desmopressin til at øge indledende periode med søvn uforstyrret af nykturi |
Country Status (16)
Country | Link |
---|---|
US (2) | US9974826B2 (da) |
EP (5) | EP2712622B1 (da) |
JP (5) | JP5767103B2 (da) |
CA (1) | CA2724653A1 (da) |
DK (5) | DK2712622T3 (da) |
ES (5) | ES2710454T3 (da) |
HR (4) | HRP20161066T1 (da) |
HU (5) | HUE030409T2 (da) |
LT (5) | LT2712622T (da) |
LU (1) | LUC00015I2 (da) |
NO (3) | NO3085381T3 (da) |
PL (5) | PL2296686T5 (da) |
PT (5) | PT3225250T (da) |
SI (4) | SI3085381T1 (da) |
TR (2) | TR201807224T4 (da) |
WO (1) | WO2009143356A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2712622B1 (en) * | 2008-05-21 | 2016-07-13 | Ferring B.V. | Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
US20100286045A1 (en) * | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
WO2015063602A1 (en) * | 2013-10-29 | 2015-05-07 | Ferring B.V. | Desmopressin and blood glucose |
CA3116290A1 (en) * | 2018-10-17 | 2020-04-23 | Nippon Chemiphar Co., Ltd. | Therapeutic or prophylactic agent for nocturnal polyuria |
US20230149330A1 (en) * | 2020-04-14 | 2023-05-18 | Nippon Chemiphar Co., Ltd. | Sleep quality improver |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (147)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH495957A (de) | 1966-09-15 | 1970-09-15 | Ceskoslovenska Akademie Ved | Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids |
US4316893A (en) * | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
US4405616A (en) | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
US3989816A (en) | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
US4285858A (en) * | 1979-10-30 | 1981-08-25 | Mt. Sinai School Of Medicine Of The City University Of N.Y. | Vasopressin analogs |
US4263283A (en) * | 1980-05-16 | 1981-04-21 | Ferring Pharmaceuticals, Inc. | Method for prophylaxis and/or treatment of sickle cell disease |
GB2111423B (en) | 1981-12-02 | 1985-06-26 | Wyeth John & Brother Ltd | Making quick-dissolving pills |
EP0084705B1 (en) | 1981-12-11 | 1987-01-14 | JOHN WYETH & BROTHER LIMITED | Process for preparing solid shaped articles |
US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
SE8306367L (sv) | 1983-11-18 | 1985-05-19 | Ferring Ab | Antidiuretiskt verkande farmaceutiskt preparat |
US4863737A (en) | 1985-05-01 | 1989-09-05 | University Of Utah | Compositions and methods of manufacture of compressed powder medicaments |
US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
IE60941B1 (en) | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
US4878892A (en) | 1987-02-10 | 1989-11-07 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
US4783450A (en) | 1987-04-13 | 1988-11-08 | Warner-Lambert Company | Use of commercial lecithin as skin penetration enhancer |
DK365389D0 (da) | 1989-07-24 | 1989-07-24 | Fertin Lab As | Antifungalt tyggegummipraeparat |
US5091186A (en) * | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
US5527288A (en) * | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
TW279133B (da) | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
SE9101022D0 (sv) * | 1991-01-09 | 1991-04-08 | Paal Svedman | Medicinsk suganordning |
US6746678B1 (en) * | 1991-02-22 | 2004-06-08 | Howard K. Shapiro | Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments |
AU653026B2 (en) | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
CA2103163C (en) | 1991-08-26 | 1998-10-20 | Mou-Ying Fu Lu | Compositions and methods for the sublingual or buccal administration of therapeutic agents |
ATE172637T1 (de) | 1991-12-24 | 1998-11-15 | Yamanouchi Pharma Co Ltd | Intrabukkal desintegrierende zubereitung und ihre herstellung |
US5298256A (en) * | 1992-04-28 | 1994-03-29 | Corint, Ltd. | Desmopressin buccal patch composition |
US5534496A (en) * | 1992-07-07 | 1996-07-09 | University Of Southern California | Methods and compositions to enhance epithelial drug transport |
US5343672A (en) | 1992-12-01 | 1994-09-06 | Scherer Ltd R P | Method for manufacturing freeze dried dosages in a multilaminate blister pack |
CA2090738C (en) | 1993-02-24 | 1996-05-21 | Hema-Quebec | Use of paf |
SE9300937L (sv) * | 1993-03-19 | 1994-09-20 | Anne Fjellestad Paulsen | Komposition för oral administrering av peptider |
US5434121A (en) * | 1993-03-25 | 1995-07-18 | Mitsui Toatsu Chemicals, Incorporated | Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same |
SE501677C2 (sv) | 1993-06-18 | 1995-04-10 | Ferring Bv | Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel |
US5985835A (en) | 1993-12-23 | 1999-11-16 | Ferring B.V. | Desmopressin for nocturia, incontinence and enuresis |
US5482931A (en) | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
US5674850A (en) * | 1993-12-23 | 1997-10-07 | Ferring Ab | High purity desmopressin produced in large single batches |
DK0710243T3 (da) * | 1993-06-29 | 2000-10-16 | Ferring Bv | Syntese af cykliske peptider |
US5500413A (en) * | 1993-06-29 | 1996-03-19 | Ferring Ab | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
HU221617B1 (hu) | 1993-06-29 | 2002-12-28 | Ferring B.V. | Vizes készítmény dezmopresszin nazális adagolására |
US5707648A (en) * | 1993-11-17 | 1998-01-13 | Lds Technologies, Inc. | Transparent liquid for encapsulated drug delivery |
SE9400918L (sv) * | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
JP2551742B2 (ja) * | 1994-05-23 | 1996-11-06 | 三星電機株式会社 | 医薬品投与用皮膚傷形成装置 |
DE4424800A1 (de) * | 1994-07-14 | 1996-01-18 | Philips Patentverwaltung | Schaltungsanordnung zum Liefern von Speisespannungen |
SE518619C2 (sv) * | 1994-12-09 | 2002-10-29 | Gs Dev Ab | Komposition för reglerad frisättning innehållande monokaproin |
GB9502879D0 (en) * | 1995-02-14 | 1995-04-05 | Oxford Biosciences Ltd | Particle delivery |
IL113459A (en) * | 1995-04-23 | 2000-07-16 | Electromagnetic Bracing System | Electrophoretic cuff apparatus |
US5843016A (en) | 1996-03-18 | 1998-12-01 | Physion S.R.L. | Electromotive drug administration for treatment of acute urinary outflow obstruction |
TW411277B (en) | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
GB9612629D0 (en) | 1996-06-17 | 1996-08-21 | Oxford Biosciences Ltd | Method for providing dense particle compositions for use in transdermal particle delivery |
AR008242A1 (es) * | 1996-06-18 | 1999-12-29 | Alza Corp | Dispositivo para atravesar el estrato corneo de una superficie corporal |
US5763398A (en) * | 1996-06-20 | 1998-06-09 | Ferring B.V. | Nasal administration of desmopressin |
US5922680A (en) * | 1996-10-23 | 1999-07-13 | Ferring, B.V. | Stabilized composition for oral administration of peptides |
SE9604341D0 (sv) | 1996-11-26 | 1996-11-26 | Ferring Bv | Hepta-peptide oxytocin analogue |
FR2758195B1 (fr) | 1997-01-09 | 1999-02-26 | Sgs Thomson Microelectronics | Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele |
US5821230A (en) | 1997-04-11 | 1998-10-13 | Ferring Bv | GnRH antagonist decapeptides |
US6194407B1 (en) * | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
US5932745A (en) * | 1997-07-30 | 1999-08-03 | American Home Products Corporation | Process for converting propargylic amine-N-oxides to enaminones |
US6511974B1 (en) * | 1997-07-30 | 2003-01-28 | Wyeth | Tricyclic vasopressin agonists |
US5948433A (en) | 1997-08-21 | 1999-09-07 | Bertek, Inc. | Transdermal patch |
US7153845B2 (en) | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US20040018241A1 (en) * | 1997-09-26 | 2004-01-29 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
US6322532B1 (en) | 1998-06-24 | 2001-11-27 | 3M Innovative Properties Company | Sonophoresis method and apparatus |
US7138393B2 (en) * | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
US6090803A (en) * | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
US6148232A (en) | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
GB9827292D0 (en) | 1998-12-12 | 1999-02-03 | Univ Strathclyde | Freeze drying |
US6406455B1 (en) * | 1998-12-18 | 2002-06-18 | Biovalve Technologies, Inc. | Injection devices |
US20060025387A1 (en) * | 1998-12-23 | 2006-02-02 | Cytoscan Sciences Llc | Compositions and methods for the treatment of disorders of the central and peripheral nervous systems |
GB9901819D0 (en) | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
US6344451B1 (en) * | 1999-02-04 | 2002-02-05 | American Home Products | Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
US6235900B1 (en) * | 1999-02-04 | 2001-05-22 | American Home Products Corporation | Tricyclic pyridine N-oxides vasopressin agonists |
US6297234B1 (en) * | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
US6620807B1 (en) | 1999-02-04 | 2003-09-16 | Wyeth | Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists |
EP1153616B1 (en) | 1999-02-15 | 2004-12-01 | Sumitomo Pharmaceuticals Company, Limited | Tablets quickly disintegrated in the oral cavity |
US6314317B1 (en) | 1999-02-18 | 2001-11-06 | Biovalve Technologies, Inc. | Electroactive pore |
AR014640A1 (es) * | 1999-02-23 | 2001-03-28 | Univ Nac Quilmes | UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE. |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US7060708B2 (en) * | 1999-03-10 | 2006-06-13 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
US6210699B1 (en) | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
GB2355454A (en) | 1999-10-20 | 2001-04-25 | Ferring Bv | Antidiuretic agents |
US6558695B2 (en) * | 1999-12-16 | 2003-05-06 | Dermatrends, Inc. | Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers |
GB0000079D0 (en) * | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
DE60144229D1 (de) | 2000-01-07 | 2011-04-28 | Valeritas Inc | Injektionsvorrichtung |
US20070032410A1 (en) * | 2000-01-11 | 2007-02-08 | Atossa Healthcare, Inc. | Compositions and methods for the treatment of psychiatric disorders |
AT409081B (de) | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
GB0015601D0 (en) * | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
TWI287984B (en) * | 2000-10-17 | 2007-10-11 | Wyeth Corp | Pharmaceutical composition for modulating bladder function |
EP2085109A3 (en) | 2000-10-26 | 2009-09-02 | Alza Corporation | Transdermal drug delivery devices having coated microprotrusions |
CA2430499C (en) | 2000-11-30 | 2012-05-22 | Biovalve Technologies, Inc. | Injection systems |
ES2717656T3 (es) | 2000-11-30 | 2019-06-24 | Valeritas Inc | Dispositivo con microsonda amovible sustancialmente libre sobre el alojamiento |
WO2002064193A2 (en) | 2000-12-14 | 2002-08-22 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
AU2002231207A1 (en) * | 2000-12-21 | 2002-07-01 | Biovalve Technologies, Inc. | Microneedle array systems |
DE60220661T2 (de) | 2001-03-16 | 2008-02-14 | Alza Corp., Mountain View | Transdermales pflaster zur verabreichung von fentanyl |
BR0208823A (pt) * | 2001-04-12 | 2004-03-09 | Wyeth Corp | Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica |
US7022699B2 (en) * | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
EP1381608B1 (en) * | 2001-04-12 | 2007-10-10 | Wyeth | Cyclohexylphenyl vasopressin agonists |
US7615234B2 (en) * | 2001-09-11 | 2009-11-10 | Glide Pharmaceutical Technologies Limited | Drug delivery technology |
EP1426355B1 (en) | 2001-09-13 | 2008-10-15 | Kissei Pharmaceutical Co., Ltd. | Crystals of hydroxynorephedrine derivative |
US6723077B2 (en) * | 2001-09-28 | 2004-04-20 | Hewlett-Packard Development Company, L.P. | Cutaneous administration system |
US6893655B2 (en) * | 2001-10-09 | 2005-05-17 | 3M Innovative Properties Co. | Transdermal delivery devices |
MY148466A (en) | 2001-10-26 | 2013-04-30 | Merck Frosst Canada Ltd | Granule formulation |
AU2002349773B2 (en) * | 2001-11-16 | 2007-12-13 | Astellas Pharma Inc. | 4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives or salts thereof |
GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
CA2484724C (en) * | 2002-05-07 | 2007-01-16 | Ferring B.V. | Pharmaceutical formulations |
US6945952B2 (en) * | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
GB2421689B (en) * | 2002-08-05 | 2007-03-07 | Caretek Medical Ltd | Drug delivery system |
WO2004030743A2 (en) * | 2002-09-30 | 2004-04-15 | Alza Corporation | Drug delivery device having coated microprojections incorporating vasoconstrictors |
US7320984B2 (en) * | 2002-10-09 | 2008-01-22 | Toray Industries, Inc. | Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
US7383084B2 (en) * | 2002-10-31 | 2008-06-03 | Transpharma Medical Ltd. | Transdermal delivery system for dried particulate or lyophilized medications |
EP1428526A1 (en) | 2002-12-13 | 2004-06-16 | Rijksuniversiteit Groningen | Formulation for fast dissolution of lipophilic compounds |
DE10259934B3 (de) * | 2002-12-20 | 2004-10-14 | H.C. Starck Gmbh | Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile |
AR042815A1 (es) * | 2002-12-26 | 2005-07-06 | Alza Corp | Dispositivo de suministro de agente activo que tiene miembros compuestos |
DK1619185T3 (da) * | 2003-04-28 | 2011-07-18 | Astellas Pharma Inc | 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt deraf |
US20060193825A1 (en) * | 2003-04-29 | 2006-08-31 | Praecis Phamaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
US7094545B2 (en) * | 2003-04-30 | 2006-08-22 | Ferring Bv | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
AU2004255228A1 (en) | 2003-06-30 | 2005-01-20 | Alza Corporation | Method for coating skin piercing microprojections |
DK1500390T3 (da) * | 2003-07-25 | 2005-09-19 | Ferring Bv | Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf |
CN1826099B (zh) | 2003-07-25 | 2010-06-09 | 凡林有限公司 | 固体剂型药物组合物及其制造方法 |
US6930932B2 (en) * | 2003-08-27 | 2005-08-16 | Hewlett-Packard Development Company, L.P. | Data signal reception latch control using clock aligned relative to strobe signal |
WO2005041871A2 (en) | 2003-10-24 | 2005-05-12 | Alza Corporation | Apparatus and method for enhancing transdermal drug delivery |
KR20060108682A (ko) * | 2003-10-24 | 2006-10-18 | 알자 코포레이션 | 경피 약물 전달을 증대시키기 위한 전처리 방법 및 장치 |
CN100571643C (zh) * | 2003-10-31 | 2009-12-23 | 阿尔扎公司 | 用于微凸起阵列的自驱动施加器 |
JP5596252B2 (ja) * | 2003-11-10 | 2014-09-24 | アラーガン、インコーポレイテッド | 低用量デスモプレシンを含有する医薬組成物 |
DK1530967T3 (da) | 2003-11-13 | 2006-07-03 | Ferring Bv | Blisterpakning og dertil hörende fast dosisform |
US7018653B2 (en) * | 2003-12-29 | 2006-03-28 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
PT1550439E (pt) | 2003-12-29 | 2006-06-30 | Ferring Bv | Metodo para a preparacao de uma forma solida de dosagem de desmopressina |
EP1706176A4 (en) * | 2004-01-09 | 2008-06-25 | Alza Corp | METHOD AND SYSTEM FOR FREQUENCY-ASSISTED TRANSDERMAL-BASED TRANSDERMAL AGENT DELIVERY |
SI1797109T1 (sl) * | 2004-09-09 | 2016-07-29 | Yeda Research And Development Co., Ltd. | Zmesi polipeptidov, sestavki, ki jih vsebujejo, in postopki za njihovo pripravo ter njihove uporabe |
US7097776B2 (en) * | 2004-10-22 | 2006-08-29 | Hewlett-Packard Development Company, L.P. | Method of fabricating microneedles |
US20060093658A1 (en) * | 2004-10-26 | 2006-05-04 | Gayatri Sathyan | Apparatus and method for transdermal delivery of desmopressin |
CN100339081C (zh) | 2004-11-10 | 2007-09-26 | 范敏华 | 一种氯雷他定口腔崩解片剂的制备方法 |
US7180274B2 (en) * | 2004-12-10 | 2007-02-20 | Aimtron Technology Corp. | Switching voltage regulator operating without a discontinuous mode |
EP1871358A1 (en) | 2005-04-22 | 2008-01-02 | Wyeth | Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists |
BRPI0610037A2 (pt) | 2005-04-22 | 2010-05-25 | Wyeth Corp | derivados de dihidrobenzofurano e uso dos mesmos |
US7856263B2 (en) | 2005-04-22 | 2010-12-21 | Travanti Pharma Inc. | Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis |
CN101218223A (zh) | 2005-04-22 | 2008-07-09 | 惠氏公司 | 苯并二烷和苯并二氧戊环衍生物及其应用 |
WO2006116150A1 (en) | 2005-04-22 | 2006-11-02 | Wyeth | Dihydrobenzofuran derivatives and uses thereof |
RU2007139541A (ru) | 2005-04-22 | 2009-05-27 | Вайет (Us) | Производные хромана и хромена и их применение |
AU2006239941A1 (en) | 2005-04-24 | 2006-11-02 | Wyeth | Methods for modulating bladder function |
WO2006138719A2 (en) | 2005-06-17 | 2006-12-28 | Georgia Tech Research Corporation | Coated microstructures and method of manufacture thereof |
US20080195035A1 (en) | 2005-06-24 | 2008-08-14 | Frederickson Franklyn L | Collapsible Patch and Method of Application |
WO2007083323A2 (en) | 2006-01-23 | 2007-07-26 | Panacea Biotec Limited. | Modified release oral dosage form comprising desmopressin |
CA2584456C (en) | 2006-03-02 | 2008-07-22 | Ferring International Center S.A. | Composition comprising desmopressin |
US8101114B2 (en) | 2006-05-01 | 2012-01-24 | Georgia Tech Research Corporation | Particle based molding |
AU2008283929B2 (en) * | 2007-08-06 | 2013-10-10 | Serenity Pharmaceuticals, Llc | Methods and devices for desmopressin drug delivery |
EP2712622B1 (en) | 2008-05-21 | 2016-07-13 | Ferring B.V. | Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia |
-
2009
- 2009-05-21 EP EP13181216.6A patent/EP2712622B1/en active Active
- 2009-05-21 LT LTEP13181216.6T patent/LT2712622T/lt unknown
- 2009-05-21 SI SI200931838T patent/SI3085381T1/en unknown
- 2009-05-21 PL PL09751584T patent/PL2296686T5/pl unknown
- 2009-05-21 HU HUE13181216A patent/HUE030409T2/en unknown
- 2009-05-21 WO PCT/US2009/044860 patent/WO2009143356A1/en active Application Filing
- 2009-05-21 PT PT171711559T patent/PT3225250T/pt unknown
- 2009-05-21 SI SI200931494A patent/SI2712622T1/sl unknown
- 2009-05-21 PT PT97515845T patent/PT2296686E/pt unknown
- 2009-05-21 TR TR2018/07224T patent/TR201807224T4/tr unknown
- 2009-05-21 DK DK13181216.6T patent/DK2712622T3/da active
- 2009-05-21 ES ES17171152T patent/ES2710454T3/es active Active
- 2009-05-21 PL PL17171155T patent/PL3225250T3/pl unknown
- 2009-05-21 JP JP2011510705A patent/JP5767103B2/ja active Active
- 2009-05-21 LT LTEP17171152.6T patent/LT3225249T/lt unknown
- 2009-05-21 NO NO16165875A patent/NO3085381T3/no unknown
- 2009-05-21 ES ES13181216.6T patent/ES2596435T3/es active Active
- 2009-05-21 DK DK17171155T patent/DK3225250T3/da active
- 2009-05-21 EP EP17171152.6A patent/EP3225249B1/en active Active
- 2009-05-21 LT LT17171155T patent/LT3225250T/lt unknown
- 2009-05-21 DK DK09751584.5T patent/DK2296686T4/da active
- 2009-05-21 NO NO09751584A patent/NO2296686T3/no unknown
- 2009-05-21 EP EP09751584.5A patent/EP2296686B2/en active Active
- 2009-05-21 DK DK17171152.6T patent/DK3225249T3/da active
- 2009-05-21 HU HUE16165875A patent/HUE039013T4/hu unknown
- 2009-05-21 LT LTEP16165875.2T patent/LT3085381T/lt unknown
- 2009-05-21 PT PT17171152T patent/PT3225249T/pt unknown
- 2009-05-21 SI SI200932000T patent/SI3225250T1/sl unknown
- 2009-05-21 HU HUE17171155A patent/HUE046050T2/hu unknown
- 2009-05-21 PT PT161658752T patent/PT3085381T/pt unknown
- 2009-05-21 SI SI200931912T patent/SI3225249T1/sl unknown
- 2009-05-21 DK DK16165875.2T patent/DK3085381T3/da active
- 2009-05-21 PL PL16165875T patent/PL3085381T3/pl unknown
- 2009-05-21 CA CA2724653A patent/CA2724653A1/en not_active Abandoned
- 2009-05-21 EP EP16165875.2A patent/EP3085381B1/en active Active
- 2009-05-21 HU HUE17171152A patent/HUE041370T2/hu unknown
- 2009-05-21 PL PL13181216T patent/PL2712622T3/pl unknown
- 2009-05-21 ES ES16165875.2T patent/ES2677548T3/es active Active
- 2009-05-21 PT PT131812166T patent/PT2712622T/pt unknown
- 2009-05-21 EP EP17171155.9A patent/EP3225250B1/en active Active
- 2009-05-21 TR TR2018/19189T patent/TR201819189T4/tr unknown
- 2009-05-21 US US12/469,801 patent/US9974826B2/en active Active
- 2009-05-21 ES ES17171155T patent/ES2756706T3/es active Active
- 2009-05-21 PL PL17171152T patent/PL3225249T3/pl unknown
- 2009-05-21 ES ES09751584.5T patent/ES2462465T5/es active Active
-
2015
- 2015-03-31 JP JP2015072698A patent/JP6001121B2/ja active Active
-
2016
- 2016-08-22 HR HRP20161066TT patent/HRP20161066T1/hr unknown
- 2016-08-31 JP JP2016169163A patent/JP6258424B2/ja active Active
-
2017
- 2017-01-20 LT LTPA2017001C patent/LTC2712622I2/lt unknown
- 2017-04-12 LU LU00015C patent/LUC00015I2/fr unknown
- 2017-12-06 JP JP2017234382A patent/JP6506821B2/ja active Active
-
2018
- 2018-01-26 US US15/880,697 patent/US20180250357A1/en not_active Abandoned
- 2018-05-17 HR HRP20180774TT patent/HRP20180774T1/hr unknown
-
2019
- 2019-01-18 HR HRP20190114TT patent/HRP20190114T1/hr unknown
- 2019-03-29 JP JP2019067813A patent/JP6836618B2/ja active Active
- 2019-04-26 HU HUS1900024C patent/HUS1900024I1/hu unknown
- 2019-04-30 NO NO2019021C patent/NO2019021I1/no unknown
- 2019-10-14 HR HRP20191854TT patent/HRP20191854T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3085381T3 (da) | Orodispersibel desmopressin til forøgelse den initielle periode af søvn uforstyret af nyturi | |
US11020448B2 (en) | Methods comprising desmopressin | |
US11963995B2 (en) | Methods comprising desmopressin |